Article
Genetic predisposition and nongenetic risk factors of thiazolidinedione-related edema in patients with type 2 diabetes.
Pharmacogenetics and genomics - 1 Dec 2011
Chang Tien-Jyun, Liu Pi-Hua, Liang Yi-Chi, Chang Yi-Cheng, Jiang Yi-Der, Li Hung-Yuan, Lo Min-Tzu, Chen Harn-Shen, Chuang Lee-Ming
Abstract excerpt
OBJECTIVE: This study aimed to analyze the association of thiazolidinedione (TZD)-related edema with genetic and clinical variables and develop a simple points system to predict the risk of developing TZD-related edema. METHODS: Fifty-eight (21.6%) of 268 individuals who received TZD for type 2 diabetes developed peripheral edema. Twenty-eight tag single nucleotide polymorphisms (SNPs) from candidate genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
